Benitec Biopharma Inc.

BNTC · Nasdaq · SIC 2834: Pharmaceutical Preparations
132
SEC Filings

Business Summary

3 Item1A. Risk Factors 28 Item 1B. Unresolved Staff Comments 70 Item 1C. Cybersecurity 70 Item 2. Properties 70 Item 3. Legal Proceedings 70 Item 4. Mine Safety Disclosures 70 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 71 Item 6. RESERVED 71 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 72 Item7A. Quantitative and Qualitative Disclosures about Market Risk 80 Item 8. Fin...

Next Earnings

Q2 FY2026 — expected 2026-09-13

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionBNTCdiscussed_in_filing Cybersecurity
topic_mentionBNTCdiscussed_in_filing Cybersecurity
topic_mentionBNTCdiscussed_in_filing Cybersecurity
topic_mentionBNTCdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-09-222025-06-300001193125-25-211361EDGAR80K words
2024-09-262024-06-300001193125-24-226968EDGAR—
2023-09-212023-06-300001193125-23-239121EDGAR—
2022-09-022022-06-300001193125-22-237075EDGAR—
2021-09-202021-06-300001193125-21-276758EDGAR—
2020-09-232020-06-300001193125-20-252381EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-02-122025-12-310001193125-26-047737EDGAR23K words
2025-11-142025-09-300001193125-25-283274EDGAR—
2025-05-142025-03-310001193125-25-119383EDGAR—
2025-02-142024-12-310001193125-25-026631EDGAR—
2024-11-142024-09-300001193125-24-258672EDGAR—
2024-05-132024-03-310001193125-24-136727EDGAR—
2024-02-132023-12-310001193125-24-032940EDGAR—
2023-11-132023-09-300001193125-23-275377EDGAR—
2023-05-152023-03-310001193125-23-144211EDGAR—
2023-02-132022-12-310001193125-23-034339EDGAR—
2022-11-102022-09-300001193125-22-281978EDGAR—
2022-05-162022-03-310001193125-22-150924EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-120001193125-26-047742EDGAR3K words
2025-12-020001193125-25-305475EDGAR—
2025-11-140001193125-25-283351EDGAR—
2025-11-070001193125-25-270490EDGAR—
2025-11-030001193125-25-261665EDGAR—
2025-09-220001193125-25-211462EDGAR—
2025-09-120000950170-25-114530EDGAR—
2025-07-090001193125-25-157095EDGAR—
2025-05-140001193125-25-119402EDGAR—
2025-03-280001193125-25-067232EDGAR—

132 total filings indexed. 104 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001808898
TickerBNTC
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: b61122b186958d0c2b96cc505a1a0ffa334f08cda2b6c3904ee4c37b45f4fd53
parent: 2490cd6a303895f29cc316929c15e4ce9729c1b663aaeb765715435acc0c7c6d
content hash: cf394382403fbb4aef304d922a4005b37d85eaffe8847905866929adfd2acdb2
signed: 2026-04-13T04:44:03.201Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf